Ласкаво просимо до нашого чату! 📱 Телеграм 🎮 Діскорд
Client
Language:
Currency:
Theme:
+38 063 063 6 420
0 0
Catalog
Home
Wishlist
0
Compare
0
Contacts

Anaphylaxis

All about product
Description
Reviews 0
Questions0
In Stock
290.00 грн.
Ex Tax: 290.00 грн.
Anaphylaxis
290.00 грн.
Description
breed by MassMedicalStrains

Here you can find all info about Anaphylaxis from MassMedicalStrains. If you are searching for information about Anaphylaxis from MassMedicalStrains, check out our: Basic infos , Gallery , Degustation , Awards , Strain Reviews , Direct Comparisons , Lineage / Genealogy , Hybrids / Crossbreeds , User comments , for this cannabis variety here at this page and follow the links to get even more information. If you have any personal experiences with growing or consuming this cannabis variety, please use the upload links to add them to the database!

Basic infos

Anaphylaxis is an mostly sativa from MassMedicalStrains and can be cultivated indoors, outdoors and greenhouse (Where the plants will need a flowering time of ±65 days) MassMedicalStrains's Anaphylaxis also available as feminized seeds.

MassMedicalStrains Description

Strong flavors of Lemon, Gasoline, Pine, Haze, and Butter. This devastating sativa dominant hybrid is designed to take you to the darkest corners of your mind and promote anxiety for the purpose of self exploration. Racy sativa effects to the extreme, this is not for casual use or for lightweight smokers. Extreme psychoactivity. A very high yielding strain, with super dense and frosty buds. Plants put on a colorful fade for the last few weeks. Vigorous and a 2.5 to 3x stretch is typical, with large buds filling out all the way to the bottom of the plant.

Bred by Mass Medical Strains in collaboration with Thug Pug Genetics.

Reviews

There are no reviews for this product.

There are no reviews for this product, be the first to leave your review.

Answers & questions
Add your question and we will answer as soon as possible.

No questions about this product, be the first and ask your question.